Chinese Journal of Pharmaceuticals
|
2022, 53(9): 1360-1364
• Pharmaceutical Management & Information •
Survey on China's Improved New Drug Development and Clinical Advantages Considerations for Registration Requirements
Full
Affiliations
- Taizhou Medical Hi-Tech Zone Public Service Platform, Taizhou 225300
Published: 2022-09-10
doi: 10.16522/j.cnki.cjph.2022.09.020
Outline
常洪委.
国内改良型新药研发现状和临床优势的注册考量.
中国医药工业杂志,
2022
, 53
(9)
: 1360
-1364
.
DOI: 10.16522/j.cnki.cjph.2022.09.020
Hongwei CHANG.
Survey on China's Improved New Drug Development and Clinical Advantages Considerations for Registration Requirements[J].
Chinese Journal of Pharmaceuticals,
2022
, 53
(9)
: 1360
-1364
.
DOI: 10.16522/j.cnki.cjph.2022.09.020
Year 2022 volume 53 Issue 9
82
13
Cite this Article
BibTeX
Article Info
doi: 10.16522/j.cnki.cjph.2022.09.020
- Receive Date:2022-04-16
- Online Date:2026-11-12
- Published:2022-09-10